Hydroxyzine Hydrochloride
- Product NDC
- 60760-285
- Requested package NDC
- 60760-285-20
- 11-digit product format
- 607600285
- Labeler code
- 60760
- Product ID
- 60760-285_4537cfd9-9816-831c-e063-6394a90a86f9
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Hydroxyzine Hydrochloride
- Dosage form
- TABLET, FILM COATED
- Route
- ORAL
- Labeler
- St Mary's Medical Park Pharmacy
- Application
- ANDA088617
- Marketing category
- ANDA
- Marketing start
- 2020-02-19
- Substance
- HYDROXYZINE DIHYDROCHLORIDE
- Active strength
- 10 mg/1
- Pharmacologic classes
- Antihistamine [EPC], Histamine Receptor Antagonists [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A088617-001 | HYDROXYZINE HYDROCHLORIDE | HYDROXYZINE HYDROCHLORIDE | 10MG | TABLET / ORAL | AB | RLD, RS | 1986-01-10 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| A088617-001 | AB |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-01 22:54:32 | 2026-06 | A088617-001 | HYDROXYZINE HYDROCHLORIDE | 10MG | TABLET / ORAL | AB | RLD, RS | 1986-01-10 | a50c72e98297… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-08-01 22:54:32 | 2026-06 | A088617-001 | AB | 1 | a50c72e98297… |
openFDA label cross-check#
Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Hydroxyzine Hydrochloride | HYDROXYZINE HYDROCHLORIDE | St Mary's Medical Park Pharmacy | 9ef6a4b7-362d-61b4-e053-2995a90a0ebb | 2026-07-28 | Warnings, Adverse reactions | 088617 ANDA088617 60760-285-20 60760-285 60760028520 |
| Hydroxyzine Hydrochloride | HYDROXYZINE HYDROCHLORIDE | American Health Packaging | 47bda4fe-ddb7-4140-900a-970373cc7acc | 2026-06-23 | Warnings, Adverse reactions | 088617 ANDA088617 |
| Hydroxyzine Hydrochloride | HYDROXYZINE HYDROCHLORIDE | PD-Rx Pharmaceuticals, Inc. | 7165a30c-09e4-4ca1-8548-bf71998ba12f | 2025-10-20 | Warnings, Adverse reactions | 088617 ANDA088617 |
| Hydroxyzine Hydrochloride | HYDROXYZINE HYDROCHLORIDE | Bryant Ranch Prepack | 93d117dd-e2bf-4daa-abe3-d4fefed3313c | 2025-09-11 | Warnings, Adverse reactions | 088617 ANDA088617 |
| Hydroxyzine Hydrochloride | HYDROXYZINE HYDROCHLORIDE | Bryant Ranch Prepack | 9c2c05e0-b123-4ddf-8b07-6bb3ca0678b5 | 2025-09-08 | Warnings, Adverse reactions | 088617 ANDA088617 |
| Hydroxyzine Hydrochloride | HYDROXYZINE HYDROCHLORIDE | Teva Pharmaceuticals USA, Inc. | 80309ec1-e5d5-4454-b8ce-67d7e6805e44 | 2025-07-31 | Warnings, Adverse reactions | 088617 ANDA088617 |
| Hydroxyzine Hydrochloride | HYDROXYZINE HYDROCHLORIDE | NuCare Pharmaceuticals,Inc. | 714a26a1-371f-ef23-e053-2a95a90a6af6 | 2024-06-10 | Warnings, Adverse reactions | 088617 ANDA088617 |
| Hydroxyzine Hydrochloride | HYDROXYZINE HYDROCHLORIDE | A-S Medication Solutions | 3946db7c-dc2d-4329-b9ac-f003d8c6d3e1 | 2024-01-05 | Warnings, Adverse reactions | 088617 ANDA088617 |
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Hydroxyzine Hydrochloride
- Listing expiration
- 2027-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| HYDROXYZINE HYDROCHLORIDE | 10 mg/1 |
Harmonized UNII identifiers#
| Identifier | FDA.report destination |
|---|---|
| 76755771U3 | Internal UNII lookup |
Harmonized SPL set identifiers#
| Identifier | FDA.report destination |
|---|---|
| 9ef6a4b7-362d-61b4-e053-2995a90a0ebb | Available on FDA.report |
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| 57311cfb-679a-da1a-b70c-8757f7fc431a | Product name | 4 | 20250516 |
| aa1826f4-97c1-4705-bdf0-3bc7d234e618 | Product name | 2 | 20190618 |
| 75cb12ee-8eb2-4f1a-a332-5743a5d0da41 | Product name | 1 | 20151110 |
| 3ca5f78b-43dc-30fe-8014-55b922af52b3 | Product name | 1 | 20140508 |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 60760-285-20 | Hydroxyzine Hydrochloride | 20 in 1 BOTTLE, PLASTIC | TABLET, FILM COATED | 20 | 3 |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 60760-285-20 | EA - Each | 60760-285 | 38e468cd-07ae-4c37-8773-9421db7c6d62 | 1 | 2020-04-20 |
DailyMed Dashboard NDC Coverage#
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 995218 | hydrOXYzine HCl 10 MG Oral Tablet | PSN | 9ef6a4b7-362d-61b4-e053-2995a90a0ebb | 3 |
| 995218 | hydroxyzine hydrochloride 10 MG Oral Tablet | SCD | 9ef6a4b7-362d-61b4-e053-2995a90a0ebb | 3 |
Packages#
| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|
| 60760-285-20 | 60760028520 | 20 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (60760-285-20) | 2020-02-19 | 0000-00-00 | No | No | Current |